Evidence for the differential co-localization of neurokinin-1 receptors with 5-HT receptor subtypes in rat forebrain

Journal of Psychopharmacology

Volumn 26, Issue 4, 2012, Pages 505-515

  Hafizi, Sepehr ^a,b   Serres, Florence ^a   Pei, Qi ^a   Totterdell, Susan ^a   Sharp, Trevor ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CAMBRIDGESHIRE AND PETERBOROUGH NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

5 HT1A receptor; 5 HT2A receptor; 5 hydroxytryptamine; antidepressant; limbic system; NK1 receptor; Substance P

Indexed keywords

NEUROKININ 1 RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR;

ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; CELLULAR DISTRIBUTION; DENTATE GYRUS; FOREBRAIN; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE MICROSCOPY; LATERAL AMYGDALA; LATERAL SEPTUM; LIMBIC SYSTEM; MALE; MEDIAL PREFRONTAL CORTEX; MEDIAL SEPTUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SEPTUM PELLUCIDUM;

ANIMALS; IMMUNOHISTOCHEMISTRY; MALE; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, NEUROKININ-1;

EID: 84860125653     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881111425969     Document Type: Article

References (110)

1. Acsady L, Katona I, Gulyas AI, et al. Immunostaining for substance P receptor labels GABAergic cells with distinct termination patterns in the hippocampus. J Comp Neurol. 1997 ; 378: 320-336
2. Anthony TE, Azmitia EC. Molecular characterization of antipeptide antibodies against the 5-HT1A receptor: evidence for state-dependent antibody binding. Brain Res Mol Brain Res. 1997 ; 50: 277-284
3. Azmitia EC, Yu I, Akbari HM, et al. Antipeptide antibodies against the 5-HT1A receptor. J Chem Neuroanat. 1992 ; 5: 289-298
4. Aznar S, Qian Z, Shah R, et al. The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain. Brain Res. 2003 ; 959: 58-67
5. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 1999 ; 38: 1083-1152
6. Blier P, Gobbi G, Haddjeri N, et al. Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response. J Psychiatry Neurosci. 2004 ; 29: 208-218
7. Boyce S, Smith D, Carlson E, et al. Intra-amygdala injection of the substance P [NK(1) receptor] antagonist L-760735 inhibits neonatal vocalisations in guinea-pigs. Neuropharmacology. 2001 ; 41: 130-137
8. Burnet PW, Harrison PJ. Substance P (NK1) receptors in the cingulate cortex in unipolar and bipolar mood disorder and schizophrenia. Biol Psychiatry. 2000 ; 47: 80-83
9. Carletti R, Corsi M, Melotto S, et al. Down-regulation of amygdala preprotachykinin A mRNA but not H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia. Eur J Neurosci. 2005 ; 21: 1712-1718
10. Chappell P. Effects of CP-122,721, a selective NK-1 receptor antagonist in patients with major depression. 42nd Annual Meeting of the New Clinical Drug Evaluation Unit (NCDEU) ; 2002 Boca Raton, FL ; 2002..
11. Chen LW, Wei LC, Liu HL, et al. Cholinergic neurons expressing substance P receptor (NK(1)) in the basal forebrain of the rat: a double immunocytochemical study. Brain Res. 2001 ; 904: 161-166
12. Clement Y, Kia KH, Daval G, et al. An autoradiographic study of serotonergic receptors in a murine genetic model of anxiety-related behaviors. Brain Res. 1996 ; 709: 229-242
13. Collin M, Backberg M, Onnestam K, et al. 5-HT1A receptor immunoreactivity in hypothalamic neurons involved in body weight control. Neuroreport. 2002 ; 13: 945-951
14. Commons KG. Neuronal pathways linking substance P to drug addiction and stress. Brain Res. 2010 ; 1314: 175-182
15. Commons KG, Connolley KR, Valentino RJ. A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders. Neuropsychopharmacology. 2003 ; 28: 206-215
16. Conley RK, Cumberbatch MJ, Mason GS, et al. Substance P (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activity. J Neurosci. 2002 ; 22: 7730-7736
17. Cornea-Hebert V, Riad M, Wu C, et al. Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J Comp Neurol. 1999 ; 409: 187-209
18. Czyrak A, Czepiel K, Mackowiak M, et al. Serotonin 5-HT1A receptors might control the output of cortical glutamatergic neurons in rat cingulate cortex. Brain Res. 2003 ; 989: 42-51
19. Doherty MD, Pickel VM. Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area. Brain Res. 2000 ; 864: 176-185
20. Dreifuss JJ, Raggenbass M. Tachykinins and bombesin excite non-pyramidal neurones in rat hippocampus. J Physiol. 1986 ; 379: 417-428
21. Ebner K, Singewald N. The role of substance P in stress and anxiety responses. Amino Acids. 2006 ; 31: 251-272
22. Ebner K, Singewald GM, Whittle N, et al. Neurokinin 1 receptor antagonism promotes active stress coping via enhanced septal 5-HT transmission. Neuropsychopharmacology. 2008 ; 33: 1929-1941
23. Ebner K, Sartori SB, Singewald N. Tachykinin receptors as therapeutic targets in stress-related disorders. Curr Pharm Des. 2009 ; 15: 1647-1674
24. Fontaine R. Novel serotonergic mechanisms and clinical experience with nefazodone. Clin Neuropharmacol. 1993 ; 16: S45 - S50
25. Freund TF, Buzsaki G. Interneurons of the hippocampus. Hippocampus. 1996 ; 6: 347-470
26. Froger N, Gardier AM, Moratalla R, et al. 5-Hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization. J Neurosci. 2001 ; 21: 8188-8197
27. Fujimura Y, Yasuno F, Farris A, et al. Decreased neurokinin-1 (substance P) receptor binding in patients with panic disorder: positron emission tomographic study with [18F]SPA-RQ. Biol Psychiatry. 2009 ; 66: 94-97
28. Furmark T, Appel L, Michelgard A, et al. Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo. Biol Psychiatry. 2005 ; 58: 132-142
29. Garlow SJ, Morilak DA, Dean RR, et al. Production and characterization of a specific 5-HT2 receptor antibody. Brain Res. 1993 ; 615: 113-120
30. George DT, Gilman J, Hersh J, et al. Neurokinin 1 receptor antagonism as a possible therapy for alcoholism. Science. 2008 ; 319: 1536-1539
31. Geracioti TD, Carpenter LL, Owens MJ, et al. Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression. Am J Psychiatry. 2006 ; 163: 637-643
32. Gerard C, Langlois X, Gingrich J, et al. Production and characterization of polyclonal antibodies recognizing the intracytoplasmic third loop of the 5-hydroxytryptamine1A receptor. Neuroscience. 1994 ; 62: 721-739
33. Geurts FJ, De Schutter E, Timmermans JP. Localization of 5-HT2A, 5-HT3, 5-HT5A and 5-HT7 receptor-like immunoreactivity in the rat cerebellum. J Chem Neuroanat. 2002 ; 24: 65-74
34. Gobbi G, Cassano T, Radja F, et al. Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function. Eur Neuropsychopharmacol. 2007 ; 17: 328-338
35. Guiard BP, Froger N, Hamon M, et al. Sustained pharmacological blockade of NK1 substance P receptors causes functional desensitization of dorsal raphe 5-HT 1A autoreceptors in mice. J Neurochem. 2005 ; 95: 1713-1723
36. Gulyas AI, Acsady L, Freund TF. Structural basis of the cholinergic and serotonergic modulation of GABAergic neurons in the hippocampus. Neurochem Int. 1999 ; 34: 359-372
37. Haddjeri N, Blier P. Sustained blockade of neurokinin-1 receptors enhances serotonin neurotransmission. Biol Psychiatry. 2001 ; 50: 191-199
38. Hahn MK, Bannon MJ. Stress-induced C-fos expression in the rat locus coeruleus is dependent on neurokinin 1 receptor activation. Neuroscience. 1999 ; 94: 1183-1188
39. Hamke M, Herpfer I, Lieb K, et al. Substance P induces expression of the corticotropin-releasing factor receptor 1 by activation of the neurokinin-1 receptor. Brain Res. 2006 ; 1102: 135-144
40. Heilig M, Thorsell A, Sommer WH, et al. Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues. Neurosci Biobehav Rev. 2010 ; 35: 334-344
41. Herpfer I, Hunt SP, Stanford SC. A comparison of neurokinin 1 receptor knock-out (NK1-/-) and wildtype mice: exploratory behaviour and extracellular noradrenaline concentration in the cerebral cortex of anaesthetised subjects. Neuropharmacology. 2005 ; 48: 706-719
42. Hodges H, Green S, Glenn B. Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination. Psychopharmacology (Berl). 1987 ; 92: 491-504
43. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav. 2002 ; 71: 533-554
44. Jakab RL, Goldman-Rakic PS. 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci U S A. 1998 ; 95: 735-740
45. Jakab RL, Goldman-Rakic PS. Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex. J Comp Neurol. 2000 ; 417: 337-348
46. Jansson A, Tinner B, Steinbusch HW, et al. On the relationship of 5-hydroxytryptamine neurons to 5-hydroxytryptamine 2A receptor-immunoreactive neuronal processes in the brain stem of rats. A double immunolabelling analysis. Neuroreport. 1998 ; 9: 2505-2511
47. Jansson A, Tinner B, Bancila M, et al. Relationships of 5-hydroxytryptamine immunoreactive terminal-like varicosities to 5-hydroxytryptamine-2A receptor-immunoreactive neuronal processes in the rat forebrain. J Chem Neuroanat. 2001 ; 22: 185-203
48. Kaneko T, Shigemoto R, Nakanishi S, et al. Morphological and chemical characteristics of substance P receptor-immunoreactive neurons in the rat neocortex. Neuroscience. 1994 ; 60: 199-211
49. Keller M, Montgomery S, Ball W, et al. Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder. Biol Psychiatry. 2006 ; 59: 216-223
50. Kia HK, Brisorgueil MJ, Daval G, et al. Serotonin1A receptors are expressed by a subpopulation of cholinergic neurons in the rat medial septum and diagonal band of Broca-a double immunocytochemical study. Neuroscience. 1996a ; 74: 143-154
51. Kia HK, Brisorgueil MJ, Hamon M, et al. Ultrastructural localization of 5-hydroxytryptamine1A receptors in the rat brain. J Neurosci Res. 1996b ; 46: 697-708
52. Kia HK, Miquel MC, Brisorgueil MJ, et al. Immunocytochemical localization of serotonin1A receptors in the rat central nervous system. J Comp Neurol. 1996c ; 365: 289-305
53. Kim DS, Kim JE, Kwak SE, et al. Seizure activity selectively reduces 5-HT1A receptor immunoreactivity in CA1 interneurons in the hippocampus of seizure-prone gerbils. Brain Res. 2007 ; 1154: 181-193
54. Kramer MS, Cutler N, Feighner J, et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science. 1998 ; 281: 1640-1645
55. Kramer MS, Winokur A, Kelsey J, et al. Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression. Neuropsychopharmacology. 2004 ; 29: 385-392
56. Lacoste B, Riad M, Descarries L. Immunocytochemical evidence for the existence of substance P receptor (NK1) in serotonin neurons of rat and mouse dorsal raphe nucleus. Eur J Neurosci. 2006 ; 23: 2947-2958
57. Lacoste B, Riad M, Ratte MO, et al. Trafficking of neurokinin-1 receptors in serotonin neurons is controlled by substance P within the rat dorsal raphe nucleus. Eur J Neurosci. 2009 ; 29: 2303-2314
58. Levita L, Mania I, Rainnie DG. Subtypes of substance P receptor immunoreactive interneurons in the rat basolateral amygdala. Brain Res. 2003 ; 981: 41-51
59. Li X, Inoue T, Abekawa T, et al. 5-HT1A receptor agonist affects fear conditioning through stimulations of the postsynaptic 5-HT1A receptors in the hippocampus and amygdala. Eur J Pharmacol. 2006 ; 532: 74-80
60. Liu HL, Cao R, Jin L, et al. Immunocytochemical localization of substance P receptor in hypothalamic oxytocin-containing neurons of C57 mice. Brain Res. 2002 ; 948: 175-179
61. Luttgen M, Ove Ogren S, Meister B. Chemical identity of 5-HT(2A) receptor immunoreactive neurons of the rat septal complex and dorsal hippocampus. Brain Res. 2004 ; 1010: 156-165
62. Luttgen M, Ogren SO, Meister B. 5-HT(1A) receptor mRNA and immunoreactivity in the rat medial septum/diagonal band of Broca-relationships to GABAergic and cholinergic neurons. J Chem Neuroanat. 2005 ; 29: 93-111
63. McDonald AJ, Mascagni F. Neuronal localization of 5-HT type 2A receptor immunoreactivity in the rat basolateral amygdala. Neuroscience. 2007 ; 146: 306-320
64. Mantyh PW, Hunt SP, Maggio JE. Substance P receptors: localization by light microscopic autoradiography in rat brain using [3H]SP as the radioligand. Brain Res. 1984 ; 307: 147-165
65. Martin P, Tissier MH, Adrien J, et al. Antidepressant-like effects of buspirone mediated by the 5-HT1A post-synaptic receptors in the learned helplessness paradigm. Life Sci. 1991 ; 48: 2505-2511
66. Martin-Ruiz R, Puig MV, Celada P, et al. Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. J Neurosci. 2001 ; 21: 9856-9866
67. Maubach KA, Martin K, Chicchi G, et al. Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus. Neuroscience. 2002 ; 109: 609-617
68. Meltzer HY, Li Z, Kaneda Y, et al. Serotonin receptors: their key role in drugs to treat schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2003 ; 27: 1159-1172
69. Michelgard A, Appel L, Pissiota A, et al. Symptom provocation in specific phobia affects the substance P neurokinin-1 receptor system. Biol Psychiatry. 2007 ; 61: 1002-1006
70. Millan MJ. The neurobiology and control of anxious states. Prog Neurobiol. 2003 ; 70: 83-244
71. Miner LA, Backstrom JR, Sanders-Bush E, et al. Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience. 2003 ; 116: 107-117
72. Mitsuhashi M, Ohashi Y, Shichijo S, et al. Multiple intracellular signaling pathways of the neuropeptide substance P receptor. J Neurosci Res. 1992 ; 32: 437-443
73. Morilak DA, Garlow SJ, Ciaranello RD. Immunocytochemical localization and description of neurons expressing serotonin2 receptors in the rat brain. Neuroscience. 1993 ; 54: 701-717
74. Myohanen TT, Venalainen JI, Garcia-Horsman JA, et al. Spatial association of prolyl oligopeptidase, inositol 1,4,5-triphosphate type 1 receptor, substance P and its neurokinin-1 receptor in the rat brain: an immunohistochemical colocalization study. Neuroscience. 2008 ; 153: 1177-1189
75. Nakajima Y, Tsuchida K, Negishi M, et al. Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cyclic AMP cascades in transfected Chinese hamster ovary cells. J Biol Chem. 1992 ; 267: 2437-2442
76. Nakaya Y, Kaneko T, Shigemoto R, et al. Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J Comp Neurol. 1994 ; 347: 249-274
77. Nocjar C, Roth BL, Pehek EA. Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group. Neuroscience. 2002 ; 111: 163-176
78. Olver JS, Ignatiadis S, Maruff P, et al. Quetiapine augmentation in depressed patients with partial response to antidepressants. Hum Psychopharmacol. 2008 ; 23: 653-660
79. Ou XM, Lemonde S, Jafar-Nejad H, et al. Freud-1: a neuronal calcium-regulated repressor of the 5-HT1A receptor gene. J Neurosci. 2003 ; 23: 7415-7425
80. Page NM. New challenges in the study of the mammalian tachykinins. Peptides. 2005 ; 26: 1356-1368
81. Papp M, Vassout A, Gentsch C. The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats. Behav Brain Res. 2000 ; 115: 19-23
82. Patel TD, Azmitia EC, Zhou FC. Increased 5-HT1A receptor immunoreactivity in the rat hippocampus following 5,7-dihydroxytryptamine lesions in the cingulum bundle and fimbria-fornix. Behav Brain Res. 1996 ; 73: 319-323
83. Paxinos G, Watson C The Rat Brain in Streretaxic Coordinates. New York, USA: Academic Press ; 1998 :
84. Peddie CJ, Davies HA, Colyer FM, et al. Colocalisation of serotonin2A receptors with the glutamate receptor subunits NR1 and GluR2 in the dentate gyrus: an ultrastructural study of a modulatory role. Exp Neurol. 2008 ; 211: 561-573
85. Pennefather JN, Lecci A, Candenas ML, et al. Tachykinins and tachykinin receptors: a growing family. Life Sci. 2004 ; 74: 1445-1463
86. Piggins HD, Samuels RE, Coogan AN, et al. Distribution of substance P and neurokinin-1 receptor immunoreactivity in the suprachiasmatic nuclei and intergeniculate leaflet of hamster, mouse, and rat. J Comp Neurol. 2001 ; 438: 50-65
87. Pompeiano M, Palacios JM, Mengod G. Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J Neurosci. 1992 ; 12: 440-453
88. Riad M, Zimmer L, Rbah L, et al. Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat. J Neurosci. 2004 ; 24: 5420-5426
89. Rotzinger S, Lovejoy DA, Tan LA. Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides. 2010 ; 31: 736-756
90. Rupniak NM, Kramer MS. Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol Sci. 1999 ; 20: 485-490
91. Rush AJ, Warden D, Wisniewski SR, et al. STAR*D: revising conventional wisdom. CNS Drugs. 2009 ; 23: 627-647
92. Santarelli L, Gobbi G, Debs PC, et al. Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc Natl Acad Sci U S A. 2001 ; 98: 1912-1917
93. Santarelli L, Saxe M, Gross C, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science. 2003 ; 301: 805-809
94. Sargent PA, Kjaer KH, Bench CJ, et al. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry. 2000 ; 57: 174-180
95. Satake H, Kawada T. Overview of the primary structure, tissue-distribution, and functions of tachykinins and their receptors. Curr Drug Targets. 2006 ; 7: 963-974
96. Schreiber R, De Vry J. Neuroanatomical basis for the antidepressant-like effects of the 5-HT(1A) receptor agonists 8-OH-DPAT and ipsapirone in the rat forced swimming test. Behav Pharmacol. 1993 ; 4: 625-636
97. Shigemoto R, Nakaya Y, Nomura S, et al. Immunocytochemical localization of rat substance P receptor in the striatum. Neurosci Lett. 1993 ; 153: 157-160
98. Sloviter RS, Ali-Akbarian L, Horvath KD, et al. Substance P receptor expression by inhibitory interneurons of the rat hippocampus: enhanced detection using improved immunocytochemical methods for the preservation and colocalization of GABA and other neuronal markers. J Comp Neurol. 2001 ; 430: 283-305
99. Stein C, Davidowa H, Albrecht D. 5-HT(1A) receptor-mediated inhibition and 5-HT(2) as well as 5-HT(3) receptor-mediated excitation in different subdivisions of the rat amygdala. Synapse. 2000 ; 38: 328-337
100. Stockmeier CA. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatr Res. 2003 ; 37: 357-373
101. Stockmeier CA, Shi X, Konick L, et al. Neurokinin-1 receptors are decreased in major depressive disorder. Neuroreport. 2002 ; 13: 1223-1227
102. Teixeira RM, Santos AR, Ribeiro SJ, et al. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice. Eur J Pharmacol. 1996 ; 311: 7-14
103. Valentino RJ, Bey V, Pernar L, et al. Substance P acts through local circuits within the rat dorsal raphe nucleus to alter serotonergic neuronal activity. J Neurosci. 2003 ; 23: 7155-7159
104. Vigna SR, Bowden JJ, McDonald DM, et al. Characterization of antibodies to the rat substance P (NK-1) receptor and to a chimeric substance P receptor expressed in mammalian cells. J Neurosci. 1994 ; 14: 834-845
105. Wang SJ, Cheng LL, Gean PW. Cross-modulation of synaptic plasticity by beta-adrenergic and 5-HT1A receptors in the rat basolateral amygdala. J Neurosci. 1999 ; 19: 570-577
106. Willins DL, Berry SA, Alsayegh L, et al. Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo. Neuroscience. 1999 ; 91: 599-606
107. Wright DE, Seroogy KB, Lundgren KH, et al. Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain. J Comp Neurol. 1995 ; 351: 357-373
108. Wu C, Yoder EJ, Shih J, et al. Development and characterization of monoclonal antibodies specific to the serotonin 5-HT2A receptor. J Histochem Cytochem. 1998 ; 46: 811-824
109. Xu T, Pandey SC. Cellular localization of serotonin(2A) (5HT(2A)) receptors in the rat brain. Brain Res Bull. 2000 ; 51: 499-505
110. Zangrossi H, Viana MB, Graeff FG. Anxiolytic effect of intra-amygdala injection of midazolam and 8-hydroxy-2-(di-n-propylamino)tetralin in the elevated T-maze. Eur J Pharmacol. 1999 ; 369: 267-270